Cariprazine, a dopamine D3-receptor-preferring partial agonist, blocks phencyclidine-induced impairments of working memory, attention set-shifting, and recognition memory in the mouse
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Cariprazine, a dopamine D3-receptor-preferring partial agonist, blocks phencyclidine-induced impairments of working memory, attention set-shifting, and recognition memory in the mouse
Authors
Keywords
Episodic memory, Working memory, Attention set-shifting, Mouse, Phencyclidine, Dopamine D<sub>3</sub> receptors
Journal
PSYCHOPHARMACOLOGY
Volume 226, Issue 1, Pages 91-100
Publisher
Springer Nature
Online
2012-10-19
DOI
10.1007/s00213-012-2896-5
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Impact of Neurocognition on Social and Role Functioning in Individuals at Clinical High Risk for Psychosis
- (2011) Ricardo E. Carrión et al. AMERICAN JOURNAL OF PSYCHIATRY
- Strain-specific cognitive deficits in adult mice exposed to early life stress.
- (2011) Mukti Mehta et al. BEHAVIORAL NEUROSCIENCE
- Cariprazine (RGH-188), a potent D3/D2 dopamine receptor partial agonist, binds to dopamine D3 receptors in vivo and shows antipsychotic-like and procognitive effects in rodents
- (2011) István Gyertyán et al. NEUROCHEMISTRY INTERNATIONAL
- Selective Blockade of Dopamine D3 Receptors Enhances while D2 Receptor Antagonism Impairs Social Novelty Discrimination and Novel Object Recognition in Rats: A Key Role for the Prefrontal Cortex
- (2011) David JG Watson et al. NEUROPSYCHOPHARMACOLOGY
- Occupancy of dopamine D2 and D3 and serotonin 5-HT1A receptors by the novel antipsychotic drug candidate, cariprazine (RGH-188), in monkey brain measured using positron emission tomography
- (2011) Nicholas Seneca et al. PSYCHOPHARMACOLOGY
- Third Generation Antipsychotic Drugs: Partial Agonism or Receptor Functional Selectivity?
- (2010) Richard Mailman et al. CURRENT PHARMACEUTICAL DESIGN
- Cariprazine (RGH-188), a Dopamine D3 Receptor-Preferring, D3/D2 Dopamine Receptor Antagonist-Partial Agonist Antipsychotic Candidate: In Vitro and Neurochemical Profile
- (2010) B. Kiss et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- A role for dopamine D2 receptors in reversal learning
- (2009) D.A. DeSteno et al. NEUROSCIENCE
- DRD3, but not COMT or DRD2, genotype affects executive functions in healthy and first-episode psychosis adolescents
- (2008) Igor Bombin et al. AMERICAN JOURNAL OF MEDICAL GENETICS PART B-NEUROPSYCHIATRIC GENETICS
- Clonidine and guanfacine attenuate phencyclidine-induced dopamine overflow in rat prefrontal cortex: Mediating influence of the alpha-2A adrenoceptor subtype
- (2008) J. David Jentsch et al. BRAIN RESEARCH
- Phencyclidine-induced cognitive deficits in mice are improved by subsequent subchronic administration of the antipsychotic drug perospirone: Role of serotonin 5-HT1A receptors
- (2008) Hiroko Hagiwara et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- Blockade of dopamine D3 receptors in frontal cortex, but not in sub-cortical structures, enhances social recognition in rats: Similar actions of D1 receptor agonists, but not of D2 antagonists
- (2008) Florence Loiseau et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- Effects of repeated treatment of phencyclidine on cognition and gene expression in C57BL/6 mice
- (2008) Simret Beraki et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- Aripiprazole ameliorates phencyclidine-induced impairment of recognition memory through dopamine D1 and serotonin 5-HT1A receptors
- (2008) Taku Nagai et al. PSYCHOPHARMACOLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started